Abbott Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Portfolio Pulse from Avi Kapoor
Abbott Laboratories is set to release its Q3 earnings on Oct. 16, with analysts expecting an EPS of $1.2 and revenue of $10.55 billion. Recent analyst ratings show positive sentiment, with several analysts raising their price targets.
October 16, 2024 | 7:53 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Abbott Laboratories is expected to report Q3 earnings with an EPS of $1.2 and revenue of $10.55 billion. Analysts have shown positive sentiment, with several raising their price targets.
The upcoming earnings report and positive analyst ratings suggest a favorable outlook for Abbott's stock. The raised price targets indicate confidence in the company's performance, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100